High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C.

被引：0
|
作者：
Kaiser, S [1 ]
Hass, H [1 ]
Gregor, M [1 ]
机构：
[1] Univ Tubingen Hosp, Tubingen, Germany
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
796
引用
收藏
页码：362A / 362A
页数：1
相关论文
共 50 条
  • [41] Efficacy of daily interferon-alpha in combination with ribavirin in the treatment of naive patients MQTH chronic hepatitis C.
    Urbanek, P
    HEPATOLOGY, 2002, 36 (04) : 578A - 578A
  • [42] High dose daily consensus interferon and ribavirin is an effective option in chronic hepatitis C patients who are nonresponders to PEG-Interferon and ribavirin
    Rothstein, KD
    Koka, R
    Hargrove, H
    Fernandez, A
    Singh, S
    Araya, V
    Munoz, SJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S122 - S122
  • [43] High-dose IFN-A induction followed by IFN plus ribavirin in treatment-naive patients with chronic hepatitis C: A prospective, randomized, controlled trial.
    Flamm, SL
    Conjeevaram, H
    Wiley, TE
    Ganger, D
    O'Riordan, K
    Jovanovic, B
    GASTROENTEROLOGY, 2000, 118 (04) : A946 - A947
  • [44] Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-α therapy
    Böcher, WO
    Schuchmann, M
    Link, R
    Hillenbrand, H
    Rahman, F
    Sprinzl, M
    Mudter, J
    Löhr, HF
    Galle, PR
    LIVER INTERNATIONAL, 2006, 26 (03) : 319 - 325
  • [45] The role of triple therapy (interferon, ribavirin and amantadine) in the treatment of chronic hepatitis C.
    Vlodov, J
    Charania, M
    Jose, RM
    Iswara, K
    Lapin, S
    Terebelo, S
    Bernstein, M
    Tenner, S
    HEPATOLOGY, 2000, 32 (04) : 565A - 565A
  • [46] Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors’ Reply
    Sean D. Sullivan
    Kavita Patel
    Jesse Green
    PharmacoEconomics, 2004, 22 : 478 - 478
  • [47] Efficacy and safety of "sandwich" therapy (initial Interferon induction with end-treatment Interferon boost) with Rebetron in the treatment of naive patients with chronic hepatitis C.
    Bassan, I
    Bloom, ML
    Phillips, RS
    Muirhead, S
    Garrison, S
    HEPATOLOGY, 2001, 34 (04) : 597A - 597A
  • [48] Treatment of chronic hepatitis B/C coinfected patients with consensus interferon/ribavirin/lamivudine triple therapy
    Kaiser, S
    Hass, HG
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
  • [49] The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C
    Chemello, L
    Cavalletto, L
    Bernardinello, E
    Guido, M
    Pontisso, P
    Alberti, A
    JOURNAL OF HEPATOLOGY, 1995, 23 : 8 - 12
  • [50] Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations
    Pariente, Alexandre
    Lahmek, Pierre
    Duprat, Christel
    Denis, Jacques
    Faroux, Roger
    Renou, Christophe
    Nalet, Bernard
    Morin, Thierry
    Cadranel, Jean-Francois
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (11) : 1297 - 1302
12345